Biotech Scientific Validation

Funding, diligence, and mechanism validation prior to capital events and regulatory milestones.

Report types in this cluster

Each report links to a dedicated page with methodology and use cases (Phase 6). Explore the cluster below.

Determine whether a target is a causal driver of disease biology.

Independent validation for investors and boards ahead of financing.

Evidence and mechanism coherence before IND-enabling work.

Cross-dataset mechanism verification and competitive intelligence.

Structured mechanism audits for diligence, targets, and mechanism decisions.